X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CANCER GENE THERAPY

期刊標題檢索 CANCER GENE THE 最新評論: What about after that, do we still have to pay even if it's not an OA... (2024-04-04)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CANCER GENE THERAPY]您好,您是該頁面的第 55060 位訪客。

期刊簡介
期刊名稱CANCER GENE THERAPY CANCER GENE THERAPY
LetPub Score
7.6
50 ratings
Rate

Reputation
8.8

Influence
6.3

Speed
9.1

期刊簡稱CANCER GENE THER
ISSN0929-1903
E-ISSN1476-5500
h-index80
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.201.4570.903
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q171 / 410
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q135 / 178
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q149 / 230

自引率 (2023-2024)2.10%自引率趨勢
掲載範囲
Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, case reports and review articles. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair.
Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.
官方網站https://www.nature.com/cgt
在線稿件提交https://mts-cgt.nature.com/
開放訪問No
出版商Springer Nature
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年1999
每年文章數123每年文章數趨勢
黃金OA百分比37.11%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOTECHNOLOGY & APPLIED MICROBIOLOGYSCIEQ127/174
GENETICS & HEREDITYSCIEQ129/191
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ145/189
ONCOLOGYSCIEQ170/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0929-1903%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【CANCER GENE THERAPY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    NATURE BIOTECHNOLOGYH-index: 399

    CiteScore: 63.00
    TRENDS IN BIOTECHNOLOGYH-index: 195

    CiteScore: 28.60
    BIOTECHNOLOGY ADVANCESH-index: 161

    CiteScore: 25.50
    MOLECULAR THERAPYH-index: 158

    CiteScore: 19.20
    PLANT BIOTECHNOLOGY JOURNALH-index: 96

    CiteScore: 20.50
    CRITICAL REVIEWS IN BIOTECHNOLOGYH-index: 79

    CiteScore: 20.80
    METABOLIC ENGINEERINGH-index: 101

    CiteScore: 15.60
    Biotechnology for BiofuelsH-index: 75

    CiteScore: 15.70
    FOOD MICROBIOLOGYH-index: 103

    CiteScore: 11.30
    學科內最受檢索的期刊 頁面查看次數
    BMC GENOMICS432071
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY409491
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY363402
    PLANT BIOTECHNOLOGY JOURNAL237452
    NATURE BIOTECHNOLOGY183707
    BIOTECHNOLOGY AND BIOENGINEERING173537
    GENOMICS168027
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY164047
    BIOTECHNOLOGY ADVANCES156128
    Biotechnology for Biofuels150310
  •  

    CANCER GENE THERAPY CANCER GENE THERAPY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [CANCER GENE THERAPY] 的評論撰寫評論
作者: 龙爪英范


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-04 08:44:48 評論於
What about after that, do we still have to pay even if it's not an OA?
(0) 讚! | 龙爪英范

作者: 八坂佑平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-13 14:53:55 評論於
And how about you, brother?
(0) 讚! | 八坂佑平

作者: 平原晓骞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-16 19:13:16 評論於
Are you choosing the non-OA mode? Do non-OA modes require processing fees?
(0) 讚! | 平原晓骞

作者: 平原晓骞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-13 10:25:30 評論於
Review speed: 3.0 | Submission hit rate: 50.0
Focus of research: Oncology
Experience sharing: Does this journal still require processing fees even though it is non-OA?
(0) 讚! | 平原晓骞

作者: Cheryl Gregory


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-13 22:24:17 評論於
May I ask what the status of "under consideration" is?
(0) 讚! | Cheryl Gregory

作者: Cheryl Gregory


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-13 12:20:26 評論於
Have you recorded the experimental data?
(0) 讚! | Cheryl Gregory

作者: 风满盼萱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-23 09:17:04 評論於
Submitted on November 28, 2022, accepted on June 21, 2023, went through three rounds of revisions in between. The first reviewer suggested acceptance, while another reviewer provided 3 comments. A third reviewer was invited for the second round of revision, who offered 4 comments. The comments from the first reviewer were all fairly positive. The third revision was temporarily accepted for further revision, and officially accepted one month later. Overall, the journal was quite slow, but as long as the revisions are made according to the requirements, there shouldn't be any issues
(0) 讚! | 风满盼萱

作者: 四风艳庆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-09 09:32:29 評論於
How to upload raw data without options?
(0) 讚! | 四风艳庆

作者: 光明熙星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-23 21:52:09 評論於
OP, I want to ask if this journal has a fast review process
(0) 讚! | 光明熙星

作者: 通幽紫琼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-05 08:41:05 評論於
Why can't I complete the submission process at the Upload Files step?
(0) 讚! | 通幽紫琼

作者: Vera Lucas


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-23 19:18:42 評論於
I will translate the following passage into English
(0) 讚! | Vera Lucas

作者: Vera Lucas


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-23 14:25:06 評論於
Fellow disciples
(0) 讚! | Vera Lucas

作者: 明冠寻露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-22 23:19:46 評論於
Is the review process of this journal fast?
(0) 讚! | 明冠寻露

作者: 暗月寺晴美


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-20 17:22:46 評論於
Is this magazine quick in reviewing manuscripts? Thank you
(0) 讚! | 暗月寺晴美

作者: 碧水微月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-03 17:12:20 評論於
May I ask if the cover letter you uploaded is a scanned handwritten document?
(0) 讚! | 碧水微月

作者: 碧水新筠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-04 14:11:54 評論於
Hello, may I ask if you have submitted to Scientific Reports?
(0) 讚! | 碧水新筠

作者: 碧水新筠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-04 13:50:30 評論於
Is bioinformatics friendly?
(0) 讚! | 碧水新筠

作者: 一只自珍呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-01 20:09:30 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Emphasized research direction: oncology; Bioinformatics experience sharing: Pure bioinformatics, rejected in 1 week, recommended to submit to scientific reports
(0) 讚! | 一只自珍呀

作者: 亚历山大沃特斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-27 16:59:08 評論於
It's been over 40 days since I submitted my work. I haven't heard anything back yet, so I want to send a follow-up
(0) 讚! | 亚历山大沃特斯

作者: Bella Carrie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-07 16:52:46 評論於
Hello, can the provided WB original film be trimmed?
(0) 讚! | Bella Carrie

作者: 一只北晶呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-06 21:33:27 評論於
How long does it usually take for you to receive revisions? It's been 42 days since I sent mine and I haven't heard anything yet. Can I follow up?
(0) 讚! | 一只北晶呀

作者: 凌春baby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-29 18:53:37 評論於
Review speed: 2.0 | Submission hit rate: 25.0 Research focus: Tumor basic research Experience sharing: WB original strips, qPCR original CT values need to be provided
(0) 讚! | 凌春baby

作者: Julian Mac


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-27 21:30:12 評論於
The review experts are very serious, but some experts may be at a starting stage. The suggestions made are occasionally bizarre, such as obviously using language grammar editing software to skim through the entire text without providing any opinions. They specifically pick out words that contradict their own opinions for examples, without actually looking into the scientific issues mentioned by the author
(0) 讚! | Julian Mac

作者: 一只北晶呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-27 11:47:38 評論於
Hello, I would like to ask when was your article submitted for review? How long does the external review usually take?
(0) 讚! | 一只北晶呀

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:21:56 評論於
The Science Citation Index (SCI) was founded in 1957 by the Institute for Scientific Information (ISI) in Philadelphia, USA. It is a citation database published by ISI in 1961. SCI, Engineering Index (EI), and ISTP (Conference Proceedings Citation Index) are the world's three major technology literature retrieval systems, and they are internationally recognized as the main tools for scientific statistics and evaluation, with SCI being the most important
(0) 讚! | 维尔娜菲茨杰拉德

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [CANCER GENE THERAPY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*